Clinical Trial Update: A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial to evaluate safety and preliminary effectiveness of CRN09682 in SST2-expressing neuroendocrine neoplasms and other solid tumors; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Neoplasm
• Neuroendocrine Tumor

Drugs mentioned

• CRN09682

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors | Phase 1, Phase 2 | Status: RECRUITING